An Interesting Read – Atezolizumab Could Change Standard of Care in Bladder Cancer – Bladder Cancer Canada Forum

< Back to Bladder Cancer Canada WebSite

SELECT YOUR LANGUAGE:

IMPORTANT: The Bladder Cancer Canada discussion forum is not a substitute for professional medical advice or treatment. The opinions & contents in this forum is for information only and is not reviewed by medical professionals. They are experiences & opinions of patient members like you, and is NOT intended to represent the best or only approach to a situation. Always consult your physician and do not rely solely on the information in this site when making decisions about your health.

This topic has 1 reply, 2 voices, and was last updated 9 years, 5 months ago by marysue.

Viewing 2 posts - 1 through 2 (of 2 total)

Author

Posts
January 19, 2016 at 6:50 pm #8338

EddieM
Participant

The investigational cancer immunotherapy atezolizumab (also known as MPDL3280A, Roche) significantly improves overall response rates (ORRs) in metastatic urothelial cancers, according to findings presented here at the Genitourinary Cancers Symposium 2016.

For more on this….click the link below:

http://www.medscape.com/viewarticle/857004

January 20, 2016 at 4:30 pm #20201

marysue
Participant

Interesting possibility. Thanks for sharing. I just hope and pray that someday BC can be treated without having to resort to RC surgery.
Author

Posts

Viewing 2 posts - 1 through 2 (of 2 total)

You must be logged in to reply to this topic.